Hot topics from the 4th international conference on osteoporosis in men

International Journal of Clinical Rheumatology

Volumn 4, Issue 1, 2009, Pages 41-44

  Bianchi, Gerolamo ^a   Giusti, Andrea ^b   Palummeri, Ernesto ^b   Girasole, Giuseppe ^a  

^a Ospedale La Colletta   (Italy)

^b Department of Gerontology and Musculoskeletal Sciences ^*  (Italy)

Author keywords

Fractures; Male; Osteoporosis; Pathogenesis; Treatment

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; GLUCAGON LIKE PEPTIDE 2; ODANACATIB; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID;

AGING; ARTICLE; AWARENESS; CASE FINDING; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; ECONOMIC ASPECT; FRAGILITY FRACTURE; HUMAN; ITALY; MALE; MORBIDITY; MORTALITY; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYMPOSIUM; WESTERN HEMISPHERE;

EID: 71049127062     PISSN: 17584272     EISSN: None     Source Type: Journal    
DOI: 10.2217/17584272.4.1.41     Document Type: Article

References (19)

1. Khosla S, Amin S, Orwoll E Osteoporosis in men. Endocr. Rev. 29, 441-464 (2008).
2. Seeman E: Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford) 47(Suppl. 4), IV2-IV8 (2008).
3. Bouxsein ML: Sex differences in bone structure, strength and the factor-of-risk. Osteoporos. Int. 19, 1657 (2008).
4. Seeman E: Bone quality: the material and structural basis of bone strength. J. Bone Miner. Metab. 26, 1-8 (2008).
5. Compston J: Histomorphometric differences between men and women. Osteoporos. Int. 19, 1662 (2008).
6. Khosla S, Riggs BL, Atkinson EJ et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J. Bone Miner. Res. 21, 124-131 (2006).
7. Black DM, Bouxsein ML, Marshall LM et al. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J. Bone Miner. Res. 23, 1326-1333 (2008).
8. Venken K, Callewaert F, Boonen S, Vanderschueren D: Sex hormones, their receptors and bone health. Osteoporos. Int. 19, 1517-1525 (2008).
9. Gennari L, Nuti R, Bilezikian JP: Aromatase activity and bone homeostasis in men. J. Clin. Endocrinol. Metab. 89, 5898-5907 (2004).
10. Vanderschueren D, Boonen S, Venken K: Androgens and the periosteum. Osteoporos. Int. 19, 1659 (2008).
11. Goemaere S, Lapauw B, Taes Y, Zmierczak H, Kaufman JM: Estrogen as a determinant of femoral bone strength in elderly men. Osteoporos. Int. 19, 1659 (2008).
12. Mellström D, Vandenput L, Mallmin H et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J. Bone Miner. Res. 23, 1552-1560 (2008).
13. Giusti A, Palummeri E, Girasole G, Pioli G, Barone A, Bianchi G: Treatment of male osteoporosis with alendronate. Osteoporos. Int. 19, 1671-1672 (2008).
14. Boonen S: Risedronate treatment in male osteoporosis. Osteoporos. Int. 19, 1671 (2008).
15. Bilezikian JP: PTH as a treatment for male osteoporosis. Osteoporos. Int. 19, 1670-1671 (2008).
16. Adami S: New drugs for osteoporosis. Osteoporos. Int. 19, 1672-1673 (2008).
17. Brown JP, Prince RL, Deal C et al. Comparison of the effect of denosumab and alendronate on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, Phase 3 trial. J. Bone Miner. Res. 24(1), 153-161 (2009).
18. Almeida M, Han L, Martin-Millan M et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 282, 27285-27297 (2007).
19. Manolagas SC, Almeida M: Gone with the Wnts: β-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21, 2605-2614 (2007).